A Phase 1, Open-Label, Drug-Drug Interaction Study to Evaluate the Effects of Multiple Oral Doses of Fluconazole and Atorvastatin on the Pharmacokinetics of a Single Oral Dose of TAK-385 in Healthy Subjects
Latest Information Update: 14 Jan 2020
At a glance
- Drugs Relugolix (Primary) ; Atorvastatin; Fluconazole
- Indications Endometriosis; Prostate cancer; Solid tumours; Uterine leiomyoma
- Focus Pharmacokinetics
- Sponsors Millennium
- 30 Apr 2014 Status changed from not yet recruiting to completed as reported by ClinicalTrials.gov record.
- 27 Mar 2014 New trial record